Abstract
Adenosine modulates several physiological functions in the CNS and in peripheral tissues via membrane receptors which have been classified into four adenosine subtypes. A1 activation produces neuronal depression: this inhibition allows A1 agonists to produce ischemic tolerance and protection in neuronal tissue. In order to selectively reproduce these effects, several A1 selective ligands have been synthesised and evaluated to understand how they interact with the adenosine A1 receptor. The investigation methods include SAR studies using native and chemically modified A1 receptors, molecular cloning of native and mutant adenosin A1 receptors, molecular modeling and thermodynamic analysis of drug-receptor interaction. Despite the great quantity of information available on the adenosine A1 receptor, no A1 agonist has so far entered in clinical use against brain diseases in view of the side effects, moreover selective A1 agonists appear to be poorly adsorbed into the brain and can be quickly degraded in vivo or in the whole blood. In an attempt to overcome these problems studies have been undertaken dealing with the use of partial agonists to inhibit side-effects and the employment of prodrugs to increase stability and diffusion through lipid barriers of A1 ligands. Other attempts involve either the use of A1 receptor enhancers as modulators able to locally enhance the action of endogenously produced adenosine, or the encapsulation of A1 agonists in drug delivery systems targeted to the brain. In this review, these approaches will be described together with the effects of adenosine A1 receptor ligands and their binding mechanisms on the central nervous system.
Current Medicinal Chemistry
Title: Adenosine A1 Receptor: Analysis of the Potential Therapeutic Effects Obtained by its Activation in the Central Nervous System
Volume: 9 Issue: 21
Author(s): Alessandro Dalpiaz and Stefano Manfredini
Affiliation:
Abstract: Adenosine modulates several physiological functions in the CNS and in peripheral tissues via membrane receptors which have been classified into four adenosine subtypes. A1 activation produces neuronal depression: this inhibition allows A1 agonists to produce ischemic tolerance and protection in neuronal tissue. In order to selectively reproduce these effects, several A1 selective ligands have been synthesised and evaluated to understand how they interact with the adenosine A1 receptor. The investigation methods include SAR studies using native and chemically modified A1 receptors, molecular cloning of native and mutant adenosin A1 receptors, molecular modeling and thermodynamic analysis of drug-receptor interaction. Despite the great quantity of information available on the adenosine A1 receptor, no A1 agonist has so far entered in clinical use against brain diseases in view of the side effects, moreover selective A1 agonists appear to be poorly adsorbed into the brain and can be quickly degraded in vivo or in the whole blood. In an attempt to overcome these problems studies have been undertaken dealing with the use of partial agonists to inhibit side-effects and the employment of prodrugs to increase stability and diffusion through lipid barriers of A1 ligands. Other attempts involve either the use of A1 receptor enhancers as modulators able to locally enhance the action of endogenously produced adenosine, or the encapsulation of A1 agonists in drug delivery systems targeted to the brain. In this review, these approaches will be described together with the effects of adenosine A1 receptor ligands and their binding mechanisms on the central nervous system.
Export Options
About this article
Cite this article as:
Dalpiaz Alessandro and Manfredini Stefano, Adenosine A1 Receptor: Analysis of the Potential Therapeutic Effects Obtained by its Activation in the Central Nervous System, Current Medicinal Chemistry 2002; 9 (21) . https://dx.doi.org/10.2174/0929867023368917
DOI https://dx.doi.org/10.2174/0929867023368917 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bone Regeneration and Repair
Current Stem Cell Research & Therapy Effect on Serum Uric Acid Levels of Drugs Prescribed for Indications other than Treating Hyperuricaemia
Current Pharmaceutical Design Pharmacological Activity of Natural Non-glycosylated Triterpenes
Mini-Reviews in Organic Chemistry Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus- Host Disease After Allogeneic Hematopoietic Cell Transplantation
Current Stem Cell Research & Therapy Mouse Models of Autoimmune Diseases: Immune Thrombocytopenia
Current Pharmaceutical Design Teenage-pregnancies from a Human Life History Viewpoint – an Updated Review with Special Respect to Prevention Strategies
Current Women`s Health Reviews Understanding the Use of Immunosuppressive Agents in the Clinical Management of IBD
Current Drug Targets 2-Chloroadenosine and Human Prostate Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Drug Evolution Concept in Drug Design: 2. Chimera Method
Medicinal Chemistry Immunotherapy-Based Strategies for the Treatment of Autoimmune Diabetes: Searching for the Cure
Current Pharmaceutical Design The Psychopharmacology of European Herbs with Cognition-Enhancing Properties
Current Pharmaceutical Design Primate-Accelerated Evolutionary Genes: Novel Routes to Drug Discovery in Psychiatric Disorders
Current Medicinal Chemistry Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
Current Pharmaceutical Design Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
Current Cancer Drug Targets Pregnancy Complicated by the Most Frequent Forms of Maturity Onset Diabetes of the Young: A Narrative Review on Its Pharmacological Implications
Current Reviews in Clinical and Experimental Pharmacology Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets α7 Nicotinic Acetylcholine Receptors: A Therapeutic Target in the Structure Era
Current Drug Targets Xenobiotic-Induced Transcriptional Regulation of Xenobiotic Metabolizing Enzymes of the Cytochrome P450 Superfamily in Human Extrahepatic Tissues
Current Drug Metabolism Beyond the HapMap Genotypic Data: Prospects of Deep Resequencing Projects
Current Bioinformatics Reproductive Effects of Low-to-Moderate Medical Radiation Exposure
Current Medicinal Chemistry